Alpha-2 adrenoceptor agonists and sepsis: improved survival? - Wikidata - awgldk - TriplyDB

Alpha-2 adrenoceptor agonists and sepsis: improved survival?

Alpha-2 adrenoceptor agonists and sepsis: improved survival?

http://www.wikidata.org/entity/Q41959101

about

Alpha-2 adrenoceptor agonists and sepsis: improved survival?

http://www.wikidata.org/entity/Q41959101

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

Alpha-2 adrenoceptor agonists and sepsis: improved survival?

@en

type

label

Alpha-2 adrenoceptor agonists and sepsis: improved survival?

@en

prefLabel

Alpha-2 adrenoceptor agonists and sepsis: improved survival?

@en

P1433

Q41959101-5DA8655D-824A-470C-9509-18E21575D4D1

P1476

Q41959101-D81870FC-B0DC-481E-B81E-B808DB2ABE57

P2093

Q41959101-05E6F839-BF05-487D-86B7-2C7DD1574330

P2860

Q41959101-094913A9-A1F8-43DF-B726-CA498F995215

Q41959101-13B8B659-C62A-4169-BD7E-D4D5C7984CCA

Q41959101-36A72D9F-6DB0-4EB3-86DC-866CB909C905

Q41959101-89B1E16D-0DD1-44DC-8BF0-23A21D2AED5B

Q41959101-9BDCD989-B485-44C1-8D9C-52873C087FEA

Q41959101-9F191979-528E-46B9-9732-715494461416

Q41959101-B59D5B4A-36BC-4817-AF38-6BBF5E08B03D

Q41959101-BA06CE57-C40D-4583-8BE9-3659C161EED1

P2888

Q41959101-22963F6E-1D65-4A4C-805C-22E9F8430683

P304

Q41959101-D6C8FB9D-7399-4CE2-9F81-78D79E518512

P31

Q41959101-40ADD161-46CB-4F22-953F-70FC0A5563F5

P356

Q41959101-C3EF90B3-B900-4D8B-B1CF-B68C72DBF62F

P433

Q41959101-676DF9B6-18EC-44D7-AA95-A448F03E557B

P478

Q41959101-26180983-6D6E-4D5A-8932-96865C61D4D8

P577

Q41959101-333F9D33-22E5-41B4-9C3F-5D5F3FFF9F22

P5875

Q41959101-4569CD81-E8C3-4FE5-91F0-067640663A32

P6179

Q41959101-0CFE685A-5029-4315-A4AF-A4682BB117E0

P698

Q41959101-BB766916-44A1-44CB-8BA7-D10432FCAB77

P921

Q41959101-19595F57-0892-4581-AA20-79138117CC72

P932

Q41959101-4F2322F9-87EC-442D-BAED-46D5D8934E78

P356

P1433

P1476

Alpha-2 adrenoceptor agonists and sepsis: improved survival?

@en

P2093

Luc Quintin

http://www.w3.org/2001/XMLSchema#string

P2860

Effect of dexmedetomidine versus lorazepam on outcome in patients with sepsis: an a priori-designed analysis of the MENDS randomized controlled trial.

Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.

Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial.

Therapy of alcohol withdrawal syndrome in intensive care unit patients following trauma: results of a prospective, randomized trial.

Increased pressor response to noradrenaline during septic shock following clonidine?

Comparison between dexmedetomidine and propofol for sedation in the intensive care unit: patient and clinician perceptions.

A phase II study to evaluate the efficacy of dexmedetomidine for sedation in the medical intensive care unit.

The efficacy of dexmedetomidine versus morphine for postoperative analgesia after major inpatient surgery.

P2888

P304

429; author reply 429

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/CC9096

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P577

2010-07-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45797707

http://www.w3.org/2001/XMLSchema#string

P6179

1037353913

http://www.w3.org/2001/XMLSchema#string

P698

20727233

http://www.w3.org/2001/XMLSchema#string

P921

P932

2945092

http://www.w3.org/2001/XMLSchema#string